Plasma Metabolomics and Long-term Mortality in Current and Former Tobacco Cigarette Users by Lung Function Impairment: A SPIROMICS Analysis.

Home > Publications > Plasma Metabolomics and Long-term Mortality in Current and Former Tobacco Cigarette Users by Lung Function Impairment: A SPIROMICS Analysis.

W.W. Labaki, S. Bose, S. Murray, C. Bosma, Y.J. Huang, R.P. Bowler, R.G. Barr, A.P. Comellas, N. Marchetti, J.M. Wells, N.N. Hansel, A. Fawzy, I. Barjaktarevic, R. Paine, M.S. Pierce, J.A. Krishnan, J. Bon, P. Woodruff, F.J. Martinez, J.L. Curtis, K.A. Stringer, M.K. Han. Plasma Metabolomics and Long-term Mortality in Current and Former Tobacco Cigarette Users by Lung Function Impairment: A SPIROMICS Analysis. American Journal of Respiratory and Critical Care Medicine. 2025 May 1; 211(Abstracts):a7688-a7688.

2025
https://researcherprofiles.org/profile/618805218

W.W. Labaki, S. Bose, S. Murray, C. Bosma, Y.J. Huang, R.P. Bowler, R.G. Barr, A.P. Comellas, N. Marchetti, J.M. Wells, N.N. Hansel, A. Fawzy, I. Barjaktarevic, R. Paine, M.S. Pierce, J.A. Krishnan, J. Bon, P. Woodruff, F.J. Martinez, J.L. Curtis, K.A. Stringer, M.K. Han